期刊文献+

临床化学自建检测系统性能确认的精密度与正确度及准确度的研究 被引量:22

Performance verification of precision, trueness, and accuracy of self-developed detection system in ;clinical chemistry
原文传递
导出
摘要 目的:探讨临床化学自建检测系统分析性能的确认方法。方法方法学评价研究。以血清肌酸激酶(CK)测定为例,选择在参考区间上限和下限以及医学决定水平(MDLs)浓度的6份实验样品,进行批内精密度(重复性)和日间精密度实验,计算批内CV和日间CV;使用5份能力验证试验(PT)定值样品、5份参考方法定值样品、40份新鲜冷冻血清与参考方法进行方法学比对3种方法进行正确度性能确认,计算在MDLs处的相对偏倚;基于MDLs处的CV、偏倚和允许总误差(TEa),绘制方法性能决定图、计算实验总误差和西格玛(σ)层级评价实验方法的准确度;实验结果与质量目标比较确认实验方法的精密度、正确度和准确度是否达到质量要求,并评价不同方法的有效性。结果6个实验样品的批内CV和日间CV均小于行标规定的最佳精密度要求(5.5%)。正确度初步评价结果显示,5份PT定值样品的平均偏倚为-8.96%,未达到行标规定的质量指标(允许偏倚为5.5%);采取纠正措施后,除1个参考方法定值样品的测定偏倚(-5.8%)略高于允许偏倚外,其余9个样品的平均偏倚均小于允许偏倚;与参考方法的比对结果显示,在MDLs处的相对偏倚均小于允许偏倚。方法性能决定图显示,在MDLs处实验方法的操作性能点均位于优秀区;在接近MDL浓度处的实验总误差分别为14.2%、10.4%和7.6%,均小于行标规定的15%;在MDLs浓度处的σ层级分别为5.9、7.5和15,达到了优秀水平。结论该自建检测系统测定血清CK的精密度、正确度和准确度性能均达到了国家行标规定的最佳质量要求,且不同方法的评价结果一致,实验可根据自身实际选择合适的评价方法。 Objective To investigate the precision, trueness, and accuracy of self-developed detection system in clinical chemistry.Methods This was a methodological evaluation.Take serum creatine kinase( CK) for instance, 6 serum sampleswith different leves ( on the upper or lower limit of the reference range or close to the medicine decide levels ( MDLs) , were collected for within-run precision( repeatability) and within-laboratory precision ( intermediate precision ) experiments.5 proficiency testing ( PT ) samples, 5 samples assigned value by reference method, and 40 fresh-frozen serums were measured and compared with reference method for trueness verification.Drawing method evaluation decision chart, calculating total errors and sigma level evaluation experiment based on the CV, bias, and allowed total errors(TEa)were used to evaluate the accuracy performance.The precision, trueness, and accuracy were compared with the quality indicators.Results The within-run precision and within-laboratory precision were less than the highest requirement of Chinese industrial standard.The mean bias was -8.96%, didn′t reachthe required standard (5.5%).After taking corrective actions, all samples but one ( -5.8%) met the required standard. Compared with the reference method, the mean bias on the MDLs was less than TEa.The performance points of the method evaluation decision chart indicated excellence performance.The total errors on MDLs were 14.2%, 10.4% and 7.6%, less than 15%.The sigma levels on MDLs were 5.9, 7.5 and 15, also achieved excellent level. Conclusions The precision, trueness, and accuracy performance of CK measured by self-developed detection system achieved excellent level of the Chinese industry standard, and the same results were found from different evaluation methods.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2016年第9期715-719,共5页 Chinese Journal of Laboratory Medicine
关键词 精密度 正确度 准确度 检测系统 方法学评价 Precision Trueness Accuracy Measuring system Methodological evaluation
  • 相关文献

参考文献13

  • 1张秀明.浅析定量检验程序分析性能验证实验方案设计[J].中华检验医学杂志,2015,38(6):428-430. 被引量:50
  • 2中国合格评审国家认可委员会.医学实验室质量和能力认可准则(ISO15189:2012,IDT)[s].2013.
  • 3WS/T 4047-2015.临床常用生化检验项目参考区间第7部分:血清乳酸脱氢酶、肌酸激酶.中华人民共和国国家卫生和计划生育委员会[S].中国标准出版社,2015:1-12.
  • 4张秀明,黄宪章,曾方银,等.临床生化检验诊断学[M].北京:人民卫生出版社,2012:867-870.
  • 5GB/T 26124-2011.临床化学体外诊断试剂(盒).中华人民共和国国家质量监督和检验检疫总局,中国国家标准化管理委员会[S].2011-05-12.
  • 6Westgard JO. Basic method validation.3rd ed[M]. Madison WI: Westgard QC Inc, 2008:102-110.
  • 7CLSL Evaluation of precision of quantitative measurement procedures ; approved guideline-third edition (EP05-A3)[S].2014.
  • 8WS/T403-2012.临床生物化学检验常规项目分析质量指标.中华人民共和国卫生部,2012.
  • 9CLSI. User verification of precision and estimation of bias; approved guideline-third edition(EP15-A3)[S].2014.
  • 10CLSI. Measurement procedure comparison and bias estimation using patient samples ; approved guideline- third edition(EP9-A3)[S].2013.

二级参考文献45

  • 1李萍,刘小娟,徐克和,黄志刚.利用Westgard标准决定图判定测定方法性能[J].临床检验杂志,2006,24(1):69-70. 被引量:27
  • 2张秀明,庄俊华,徐宁,黄宪章,陈茶,尹一兵,梁伟雄.不同检测系统血清酶测定结果的偏倚评估与可比性研究[J].中华检验医学杂志,2006,29(4):346-349. 被引量:137
  • 3National Cholesterol Education Program Laboratory Standardization Panel.Current status of blood cholesterol measurement in clinical laboratories in the United States.Clin Chem,1988,34:193-201.
  • 4Bachorik PS,Ross JW.National cholesterol education program recommendations for measurement of low-density lipoprotein cholesterol:executive summary.Clin Chem,1995,41:1414-1420.
  • 5Stein EA,Myers GL.National cholesterol education program recommendations for triglyceride measurement:executive summary.Clin Chem,1995,41:1421-1426.
  • 6Warnick GR,Wood PD.National cholesterol education program recommendations for measurement of high-density lipoprotein cholesterol:executive summary.Clin Chem,1995,41:1427-1433.
  • 7American Diabetes Association.Self-monitoring of blood glucose.Diabetes Care,1996,19:S62-S66.
  • 8Fraser CG,Petersen HP,Ricos C,et al.Proposed quality specifications for the imprecision and inaccuracy of analytical systems in clinical chemistry.Eur J Clin Chem Clin Biochem,1992,30:311-317.
  • 9Thienpont L,Franzini C,Kratochvila J,et al.Analytical quality specifications for reference methods and operating specifications for networks of reference laboratories.Eur J Clin Chem Clin Biochem,1995,33:949-957.
  • 10Fred SA,Mauro P,Jan R,et al.Quality specifications for B-Type natriuretic peptide assays.Clin Chem,2005,51:486-493.

共引文献204

同被引文献99

引证文献22

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部